Highly sensitive and specific LC-MS/MS method to determine endogenous leukotriene B4 levels in human plasma

Bioanalysis. 2019 Jun;11(11):1055-1066. doi: 10.4155/bio-2019-0021.

Abstract

Aim: To develop a high sensitivity and specific analytical method to measure endogenous levels of leukotriene B4 (LTB4) in human plasma. Methodology: LC-MS/MS and ELISA. Results: An LC-MS/MS method was developed with a sensitivity of 1.0 pg/ml, and within and between batch precision of <16% and <13% RSD, respectively. Conclusion: We have developed a sensitive LC-MS/MS method that can detect endogenous LTB4 in human plasma. The LC-MS/MS method displayed correlation with a commercial LTB4 ELISA when analyzing in ex vivo ionophore-stimulated blood samples. For untreated plasma this correlation was lost. Endogenous LTB4 was shown to be unstable in plasma during storage at -20°C and subject to stereoisomer formation. Neither of the assays could quantify endogenous plasma LTB4 in samples stored for long term.

Keywords: ELISA; FLAP; LC–MS; LTB; leukotriene B4.

MeSH terms

  • Chromatography, Liquid
  • Clinical Trials, Phase I as Topic
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Leukotriene B4 / antagonists & inhibitors
  • Leukotriene B4 / blood*
  • Leukotriene B4 / chemistry
  • Male
  • Molecular Structure
  • Tandem Mass Spectrometry

Substances

  • Leukotriene B4